Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids.

He J, Luster TA, Thorpe PE.

Clin Cancer Res. 2007 Sep 1;13(17):5211-8.

PMID:
17785577
[PubMed - indexed for MEDLINE]
Free Article
2.

Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice.

Ran S, He J, Huang X, Soares M, Scothorn D, Thorpe PE.

Clin Cancer Res. 2005 Feb 15;11(4):1551-62.

PMID:
15746060
[PubMed - indexed for MEDLINE]
Free Article
3.

Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma.

He J, Yin Y, Luster TA, Watkins L, Thorpe PE.

Clin Cancer Res. 2009 Nov 15;15(22):6871-80. doi: 10.1158/1078-0432.CCR-09-1499. Epub 2009 Nov 3.

PMID:
19887482
[PubMed - indexed for MEDLINE]
Free Article
4.
5.

Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors.

Liang Y, Besch-Williford C, Benakanakere I, Thorpe PE, Hyder SM.

Breast Cancer Res Treat. 2011 Jan;125(2):407-20. doi: 10.1007/s10549-010-0851-x. Epub 2010 Mar 27.

PMID:
20349129
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Antitumor effects of a bispecific antibody targeting CA19-9 antigen and CD16.

Garcia de Palazzo I, Holmes M, Gercel-Taylor C, Weiner LM.

Cancer Res. 1992 Oct 15;52(20):5713-9.

PMID:
1394194
[PubMed - indexed for MEDLINE]
Free Article
7.

Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance.

Gupta VK, Jaskowiak NT, Beckett MA, Mauceri HJ, Grunstein J, Johnson RS, Calvin DA, Nodzenski E, Pejovic M, Kufe DW, Posner MC, Weichselbaum RR.

Cancer J. 2002 Jan-Feb;8(1):47-54.

PMID:
11895203
[PubMed - indexed for MEDLINE]
8.

Increased exposure of anionic phospholipids on the surface of tumor blood vessels.

Ran S, Downes A, Thorpe PE.

Cancer Res. 2002 Nov 1;62(21):6132-40.

PMID:
12414638
[PubMed - indexed for MEDLINE]
Free Article
9.

Anti-alphav integrin monoclonal antibody intetumumab enhances the efficacy of radiation therapy and reduces metastasis of human cancer xenografts in nude rats.

Ning S, Tian J, Marshall DJ, Knox SJ.

Cancer Res. 2010 Oct 1;70(19):7591-9. doi: 10.1158/0008-5472.CAN-10-1639. Epub 2010 Sep 14.

PMID:
20841470
[PubMed - indexed for MEDLINE]
Free Article
11.

Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.

Kawase I, Komuta K, Hara H, Inoue T, Hosoe S, Ikeda T, Shirasaka T, Yokota S, Tanio Y, Masuno T, et al.

Cancer Res. 1988 Mar 1;48(5):1173-9.

PMID:
3257715
[PubMed - indexed for MEDLINE]
Free Article
12.

Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.

Buchsbaum DJ, Wahl RL, Normolle DP, Kaminski MS.

Cancer Res. 1992 Dec 1;52(23):6476-81.

PMID:
1423295
[PubMed - indexed for MEDLINE]
Free Article
13.

Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation.

Nishikawa T, Ramesh R, Munshi A, Chada S, Meyn RE.

Mol Ther. 2004 Jun;9(6):818-28.

PMID:
15194048
[PubMed - indexed for MEDLINE]
14.

Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.

Pietras RJ, Poen JC, Gallardo D, Wongvipat PN, Lee HJ, Slamon DJ.

Cancer Res. 1999 Mar 15;59(6):1347-55.

PMID:
10096569
[PubMed - indexed for MEDLINE]
Free Article
15.

Endostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in mice.

Wen QL, Meng MB, Yang B, Tu LL, Jia L, Zhou L, Xu Y, Lu Y.

Cancer Sci. 2009 Aug;100(8):1510-9. doi: 10.1111/j.1349-7006.2009.01193.x. Epub 2009 May 21.

PMID:
19459845
[PubMed - indexed for MEDLINE]
16.

Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts.

Kozin SV, Boucher Y, Hicklin DJ, Bohlen P, Jain RK, Suit HD.

Cancer Res. 2001 Jan 1;61(1):39-44.

PMID:
11196192
[PubMed - indexed for MEDLINE]
Free Article
17.

Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.

Bianco C, Bianco R, Tortora G, Damiano V, Guerrieri P, Montemaggi P, Mendelsohn J, De Placido S, Bianco AR, Ciardiello F.

Clin Cancer Res. 2000 Nov;6(11):4343-50.

PMID:
11106252
[PubMed - indexed for MEDLINE]
Free Article
18.

Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.

Seon BK, Matsuno F, Haruta Y, Kondo M, Barcos M.

Clin Cancer Res. 1997 Jul;3(7):1031-44.

PMID:
9815781
[PubMed - indexed for MEDLINE]
Free Article
19.

Combined therapy with anti-P-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in NK cell-depleted SCID mice.

Yano S, Hanibuchi M, Nishioka Y, Nokihara H, Nishimura N, Tsuruo T, Sone S.

Int J Cancer. 1999 Jul 2;82(1):105-11.

PMID:
10360828
[PubMed - indexed for MEDLINE]
20.

Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.

Pietras RJ, Pegram MD, Finn RS, Maneval DA, Slamon DJ.

Oncogene. 1998 Oct 29;17(17):2235-49.

PMID:
9811454
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk